Inflammation in gastrointestinal disorders: prevalent socioeconomic factors

References

• Ribaldone DG, Pellicano R, Actis GC. Inflammation: a highly conserved Janus-like phenomenon – a gastroenterologist’ perspective. J Mol Med. 2018;96:861–871. doi:10.1007/s00109-018-1668-z29987405
   PubMed Web of Science ®Google Scholar
• Bennett JM, Reeves G, Billman GE, Sturmberg JP. Inflammation–nature’s way to efficiently respond to all types of challenges: implications for understanding and managing “the epidemic” of chronic diseases. Front Med. 2018;5:316. doi:10.3389/fmed.2018.00316
   PubMed Web of Science ®Google Scholar
• Malekzadeh MM, Vahedi H, Gohari K, et al. Emerging epidemic of inflammatory bowel disease in a middle income country: a nation-wide study from Iran. Arch Iran Med. 2016;19:2–15. doi:10.161901/AIM.00326702742
   PubMed Web of Science ®Google Scholar
• Aller MA, Arias N, Fuentes-Julian S, et al. Coupling inflammation with evo-devo. Med Hypotheses. 2012;78:721–731. doi:10.1016/j.mehy.2012.02.01822405850
   PubMed Web of Science ®Google Scholar
• Gruppen EG, Connelly MA, Sluiter WJ, Bakker SJL, Dullaart RPF. Higher plasma GlycA, a novel pro-inflammatory glycoprotein biomarker, is associated with reduced life expectancy: the PREVEND study. Clin Chim Acta. 2018;488:7–12. doi:10.1016/j.cca.2018.10.02930365925
   PubMed Web of Science ®Google Scholar
• Ribaldone DG, Pellicano R, Actis GC. Pathogenesis of IBD: basic science in the light of real-world epidemiology. Gastrointestinal Disord. 2019;1:129–146. doi:10.3390/gidisord1010010
   Google Scholar
• Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22–34. doi:10.1038/nri.2015.526711676
   PubMed Web of Science ®Google Scholar
• Russo R, Cristiano C, Avagliano C, et al. Gut-brain axis: role of lipids in the regulation of inflammation, pain and CNS diseases. Curr Med Chem. 2018;25:3930–3952. doi:10.2174/092986732466617021611375628215162
   PubMed Web of Science ®Google Scholar
• Quigley EM. Overlapping irritable bowel syndrome and IBD: less to this than meets the eye? Therap Adv Gastroenterol. 2016;9:199–212. doi:10.1177/1756283X15621230
   PubMed Web of Science ®Google Scholar
• Ng QX, Soh AYS, Loke W, Lim DY, Yeo W-S. The role of inflammation in irritable bowel syndrome (IBS). J Inflamm Res. 2018;11:345–349. doi:10.2147/JIR.S17498230288077
   PubMed Web of Science ®Google Scholar
• O’Sullivan M, Clayton N, Breslin NP, et al. Increased mast cells in irritable bowel syndrome. Neurogastroenterol Motil. 2000;12:449–457.11012945
   PubMed Web of Science ®Google Scholar
• Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: incidence and prognosis of post-infectious IBS. Aliment Pharmacol Ther. 2007;26:535–544. doi:10.1111/j.1365-2036.2007.03399.x17661757
   PubMed Web of Science ®Google Scholar
• Alamro RA, Mustafa M, Al-Asmari A. Inflammatory gene mRNA expression in human peripheral blood and its association with colorectal cancer. J Inflamm Res. 2018;11:351–357. doi:10.2147/JIR.S15550730288078
   PubMed Web of Science ®Google Scholar
• Wang D, Wang H, Brown J, et al. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med. 2006;203:941–951. doi:10.1084/jem.2005212416567391
   PubMed Web of Science ®Google Scholar
• Alessandria C, Caviglia GP, Campion D, et al. HLA-DQ genotyping, duodenal histology, and response to exclusion diet in autistic children with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr. 2019;69:39–44. [Epub ahead of print]. doi:10.1097/MPG.000000000000229331232884
   PubMed Web of Science ®Google Scholar
• Barmeyer C, Schumann M, Meyer T, Zielinski C. Long-term response to gluten-free diet as evidence for non-celiac wheat sensitivity in one third of patients with diarrhea dominant and mixed-type irritable bowel syndrome. Int J Colorectal Dis. 2017;32:29–39. doi:10.1007/s00384-016-2663-x27695975
   PubMed Web of Science ®Google Scholar
• Pietzak M. Celiac disease, wheat allergy, and gluten sensitivity: when gluten free is not a fad. JPEN. 2012;36(Suppl 1):68S–75S. doi:10.1177/0148607111426276
   Web of Science ®Google Scholar
• Vernia P, Gnaedinger A, Hauck W, Breuer RI. Organic anions and the diarrhea of inflammatory bowel disease. Dig Dis Sci. 1988;33:1353–1358. doi:10.1007/BF015369873180970
   PubMed Web of Science ®Google Scholar
• Carding S, Verbeke K, Vipond DT, et al. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis. 2015;26:26191.25651997
   PubMed Web of Science ®Google Scholar
• Campion D, Ponzo P, Alessandria C, Saracco GM, Balzola F. The role of microbiota in autism spectrum disorders. Minerva Gastroenterol Dietol. 2018;64:333–350. doi:10.23736/S1121-421X.18.02493-529600698
   PubMed Web of Science ®Google Scholar
• Du C, Zhang B, He Y, et al. Biological effect of aqueous C60 aggregates on Scenedesmus obliquus revealed by transcriptomics and non-targeted metabolomics. J Hazard Mater. 2017;324:221–229. doi:10.1016/j.jhazmat.2016.10.05228340994
   PubMed Web of Science ®Google Scholar
• Asquith M, Powrie F. An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer. J Exp Med. 2010;207:1573–1577. doi:10.1084/jem.2010133020679404
   PubMed Web of Science ®Google Scholar
• Baumgart M, Dogan B, Rishniw M, et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn’s disease involving the ileum. Isme J. 2007;1:403–418. doi:10.1038/ismej.2007.3918043660
   PubMed Web of Science ®Google Scholar
• Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA. 2007;104:13780–13785. doi:10.1073/pnas.070662510417699621
   PubMed Web of Science ®Google Scholar
• Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe. 2014;15:382–392. doi:10.1016/j.chom.2014.02.00524629344
   PubMed Web of Science ®Google Scholar
• Segain J, De Blétière DR, Bourreillea A, et al. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn’s disease. Gut. 2000;47:397–403. doi:10.1136/gut.47.1.1410940278
   PubMed Web of Science ®Google Scholar
• Vanhoutvin SA, Troost FJ, Hamer HM, et al. Butyrate-induced transcriptional changes in human colonic mucosa. PLoS One. 2009;4:e6759. doi:10.1371/journal.pone.000675919707587
   PubMed Web of Science ®Google Scholar
• Sokol H, Seksik P, Furet JP, et al. Low counts of faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15:1183–1189. doi:10.1002/ibd.2090319235886
   PubMed Web of Science ®Google Scholar
• Laserna-Mendieta EJ, Clooney AG, Carretero-Gomez JF. Determinants of reduced genetic capacity for butyrate synthesis by the gut microbiome in Crohn’s disease and ulcerative colitis. J Crohns Colitis. 2018;12:204–216. doi:10.1093/ecco-jcc/jjx13729373727
   PubMed Web of Science ®Google Scholar
• Singh RK, Chang HW, Yan D, et al. Influence of diet on the gut microbiome and implications for human health. J Transl Med. 2017;15:73. doi:10.1186/s12967-017-1175-y28388917
   PubMed Web of Science ®Google Scholar
• Carvalho-Wells AL, Helmolz K, Nodet C, et al. Determination of the in vivo prebiotic potential of a maize-based whole grain breakfast cereal: a human feeding study. Br J Nutr. 2010;104:1353–1356. doi:10.1017/S000711451000208420487589
   PubMed Web of Science ®Google Scholar
• Cuervo A, Valdés L, Salazar N, et al. Pilot study of diet and microbiota: interactive associations of fibers and polyphenols with human intestinal bacteria. J Agric Food Chem. 2014;62:5330–5336. doi:10.1021/jf501546a24877654
   PubMed Web of Science ®Google Scholar
• Ng QX, Soh AY, Loke W, Venkatanarayanan N, Lim D, Yeo W-S. A meta-analysis of the clinical use of curcumin for irritable bowel syndrome (IBS). J Clin Med. 2018;7:298. doi:10.3390/jcm7100298
   Web of Science ®Google Scholar
• Olaisen M, Spigset O, Flatberg A, et al. Mucosal 5-aminosalicylic acid concentration, drug formulation and mucosal microbiome in patients with quiescent ulcerative colitis. Aliment Pharmacol Ther. 2019;49:1301–1313. doi:10.1111/apt.1522730895635
   PubMed Web of Science ®Google Scholar
• Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–124. doi:10.1038/nature1158223128233
   PubMed Web of Science ®Google Scholar
• Rubino SJ, Selvanantham T, Girardin SE, Philpott DJ. Nod-like receptors in the control of intestinal inflammation. Curr Opin Immunol. 2012;24:398–404. doi:10.1016/j.coi.2012.04.01022677577
   PubMed Web of Science ®Google Scholar
• Girardin SE, Boneca IG, Viala J, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003;278:8869–8872. doi:10.1074/jbc.C20065120012527755
   PubMed Web of Science ®Google Scholar
• Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002;70:845–857. doi:10.1086/34044911875755
   PubMed Web of Science ®Google Scholar
• Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005;307:731–734. doi:10.1126/science.110491115692051
   PubMed Web of Science ®Google Scholar
• Travassos LH, Carneiro LA, Ramjeet M, et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol. 2010;11:55–62. doi:10.1038/ni.182319898471
   PubMed Web of Science ®Google Scholar
• Pellicano R, Ribaldone DG, Fagoonee S, Astegiano M, Saracco GM, Mégraud F. A 2016 panorama of H Pylori infection: key messages for clinicians. Panminerva Med. 2016;58:304–317.27716738
   PubMed Web of Science ®Google Scholar
• Lee M, Baek H, Park JS, et al. Current Helicobacter pylori infection is significantly associated with subclinical coronary ATHEROSCLEROSIS in healthy subjects: a cross-sectional study. PLoS One. 2018;13:e0193646. doi:10.1371/journal.pone.019364629499055
   PubMed Web of Science ®Google Scholar
• McGee DJ, Lu XK, Disbrow EA. Stomaching the possibility of a pathogenic role for H pylori in Parkinson’s disease. J Parkinson’s Dis. 2018;8:367–374. doi:10.3233/JPD-18132729966206
   PubMedGoogle Scholar
• Ribaldone DG, Fagoonee S, Hickman I, Altruda F, Saracco GM, Pellicano R. Helicobacter pylori infection and ischemic heart disease: could experimental data lead to clinical studies? Minerva Cardioangiol. 2016;64:686–696.27603552
   PubMed Web of Science ®Google Scholar
• Jafarzadeh A, Hassanshahi GH, Nemati M. Serum levels of high-sensitivity C-reactive protein (hs-CRP) in Helicobacter pylori-infected peptic ulcer patients and its association with bacterial CagA virulence factor. Dig Dis Sci. 2009;54:2612–2616. doi:10.1007/s10620-008-0686-z19160050
   PubMed Web of Science ®Google Scholar
• Vermeire S, Van Assche G, Rutgeerts P. C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:661–665. doi:10.1097/00054725-200409000-0002615472532
   PubMed Web of Science ®Google Scholar
• Mehmet N, Refik M, Harputluoglu M, et al. Serum and gastric fluid levels of cytokines and nitrates in gastric diseases infected with helicobacter pylori. New Microbiol. 2004;27:139–148.15164624
   PubMed Web of Science ®Google Scholar
• Ng QX, Venkatanarayanan N, De Deyn MLZQ, et al. A meta-analysis of the association between Helicobacter pylori (H. pylori) infection and hyperemesis gravidarum. Helicobacter. 2018;23:e12455. doi:10.1111/hel.2018.23.issue-1
   Web of Science ®Google Scholar
• Chang J, Streitman D. Physiologic adaptations to pregnancy. Neurol Clin. 2012;30:781‐9. doi:10.1016/j.ncl.2012.05.001
   Web of Science ®Google Scholar
• Mansour G, Nashaat E. Role of helicobacter pylori in the pathogenesis of hyperemesis gravidarum. Arch Gynecol Obstet. 2010;284:843‐7.
   Web of Science ®Google Scholar
• Zhu TH, Zhu TR, Tran KA, Sivamani RK, Shi VY. Epithelial barrier dysfunction in atopic dermatitis: a skin-gut-lung model linking microbiome alteration and immune dysregulation. Br J Dermatol. 2018;179:570–581. doi:10.1111/bjd.1673429761483
   PubMed Web of Science ®Google Scholar
• Actis GC. The changing face of IBD: etiology, physiopathology, epidemiology. Ann Colorectal Res. 2016;4:e32942.
   Google Scholar
• Barko PC, McMichael MA, Swanson KS, Williams DA. The gastrointestinal microbiome: a review. J Vet Intern Med. 2018;32:9–25. doi:10.1111/jvim.1487529171095
   PubMed Web of Science ®Google Scholar
• Allen PB, Olivera P, Emery P, et al. Review article: moving towards common therapeutic goals in Crohn’s disease and rheumatoid arthritis. Aliment Pharmacol Ther. 2017;45:1058–1072. doi:10.1111/apt.1399528247573
   PubMed Web of Science ®Google Scholar
• Colombel JF, Panaccione R, Bossuyt P, et al. Effect of tight control management on Crohn’s disease (CALM): a multicentre, randomised, controlled phase 3 trial. Lancet. 2018;390:2779–2789. doi:10.1016/S0140-6736(17)32641-729096949
   PubMed Web of Science ®Google Scholar
• Caviglia GP, Ribaldone DG, Rosso C, Saracco GM, Astegiano M, Pellicano R. Fecal calprotectin: beyond intestinal organic diseases. Panminerva Med. 2018;60:29–34. doi:10.23736/S0031-0808.18.03405-529370679
   PubMed Web of Science ®Google Scholar
• Tsai HH. Editorial: tofacitinib and Biologics for moderate-to-severe ulcerative colitis – what is best in class? Aliment Pharmacol Ther. 2018;47:539–540. doi:10.1111/apt.1448029341281
   PubMed Web of Science ®Google Scholar
• Bibbò S, Ianiro G, Gasbarrini A, Cammarota G. Fecal microbiota transplantation: past, present and future perspectives. Minerva Gastroenterol Dietol. 2017;63:420–430. doi:10.23736/S1121-421X.17.02374-128927251
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Surette MG, Kim PT, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149:102–9.e6. doi:10.1053/j.gastro.2015.04.00125857665
   PubMed Web of Science ®Google Scholar
• Paramsothy S, Kamm MA, Kaakoush NO, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. 2017;389:1218–1228. doi:10.1016/S0140-6736(17)30182-428214091
   PubMed Web of Science ®Google Scholar
• Actis GC. Inflammatory bowel disease 2018: consistency and controversy. Immunome Res. 2018;14:2. doi:10.4172/1745-7580
   Google Scholar
• Ouyang JQ, Isaksson C, Schmidt C, Hutton P, Bonier F, Dominoni D. A new framework for urban ecology: an integration of proximate and ultimate responses to anthropogenic change. Integr Comp Biol. 2018;58:915–918. doi:10.1093/icb/icy11030376106
   PubMed Web of Science ®Google Scholar
• Fiocchi C. Inflammatory bowel disease: complexity and variability need integration. Front Med (Lausanne). 2018;5:75. doi:10.3389/fmed.2018.0007529619371
   PubMed Web of Science ®Google Scholar